Eloxx Pharmaceuticals Inc (NASDAQ:ELOX)

0.286
Delayed Data
As of 3:21pm ET
 -0.0394 / -12.11%
Today’s Change
0.21
Today|||52-Week Range
1.89
-59.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues75.0K75.0K0.000.00
 
 
 
Depreciation And Amortization177.1K93.4K39.0K216.0K
 
 
 
 
 
 
Operating ExpensesGross Income---18.4K-39.0K-216.0K
 
 
 
 
General Expenses7.7M3.5M20.4M46.8M
 
 
 
 
 
Other Operating Expenses258.7K181.4K0.000.00
 
 
 
Research And Development4.8M2.1M16.4M20.5M
 
 
 
 
 
Total Operating Expenses8.2M3.8M20.4M47.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.1M-3.7M-20.4M-47.0M
 
 
 
 
 
Extraordinary Credit458.4K2.2M0.000.00
 
 
 
Extraordinary Charge-10.4M-7.5M0.00-594.0K
 
 
 
 
Interest Expense On Debt0.000.00668.0K7.0K
 
 
 
Other Expenses-2.8K-530.00-156.0K-92.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.1M-8.9M-21.2M-47.1M
 
 
 
 
 
Income Taxes0.00-680.0K0.00-122.0K
 
 
 
Preferred Dividend-838.9K-179.2K-2.4M0.00
 
 
 
 
Net Income-18.1M-8.3M-21.2M-47.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS720.9K1.0M5.0M32.4M
 
 
 
 
 
Shares To Calculate EPS Diluted720.9K1.0M5.0M32.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$26.20-$8.40-$4.75-$1.45
 
 
 
 
 
EPS Diluted-$26.20-$8.40-$4.75-$1.45